Its Herceptin biosimilar nearing launch, Celltrion begins work on Keytruda copy
The decline in numbers of healthcare professionals (HCPs) willing to contribute to market research could have a detrimental effect on the quality of data provided to pharma. John Aitchison reports on why fewer are willing to join in and offers five changes that need to be made to improve uptake.
A new report from the Nuffield Trust backs concerns among general practice that new tech-based entrants could do more harm than good for the NHS. But that doesn’t mean the search for new solutions ends there
Adaptive Designs in Clinical Trials